
CapsoVision
Founded Year
2006Stage
IPO | IPOTotal Raised
$99.29MDate of IPO
7/2/2025About CapsoVision
CapsoVision specializes in diagnostic imaging of the gastrointestinal system within the medical device industry. Its main product, CapsoCam Plus, is a capsule endoscopy system that offers a complete 360° panoramic view designed to improve diagnostic confidence and patient convenience. It also provides CapsoCloud, a cloud-based software that allows for access and review of capsule endoscopy results. It was founded in 2006 and is based in Saratoga, California.
Loading...
Loading...
Research containing CapsoVision
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned CapsoVision in 1 CB Insights research brief, most recently on Oct 28, 2025.

Oct 28, 2025 report
State of Digital Health Q3’25 ReportExpert Collections containing CapsoVision
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CapsoVision is included in 1 Expert Collection, including Digital Health.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
CapsoVision Patents
CapsoVision has filed 112 patents.
The 3 most popular patent topics include:
- endoscopy
- digestive system surgery
- image processing

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/19/2021 | 4/2/2024 | Endoscopy, Video compression, Digital photography, Video codecs, Digestive system | Grant |
Application Date | 6/19/2021 |
|---|---|
Grant Date | 4/2/2024 |
Title | |
Related Topics | Endoscopy, Video compression, Digital photography, Video codecs, Digestive system |
Status | Grant |
Latest CapsoVision News
Oct 30, 2025
Conference Call Scheduled for Thursday, November 13, 2025 at 4:30 pm ET October 30, 2025 16:05 ET CapsoVision SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company will release third quarter 2025 financial results on Thursday, November 13, 2025, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results and provide a corporate update. Individuals interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and referencing conference ID 2181260, or from the webcast link on the Events page in the investor relations section of the company’s website. To access the replay, please register via the webcast link on the Events page. The webcast will be available for one year following the completion of the call. About CapsoVision CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and diagnosis of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit www.capsovision.com . Investor Relations Contact
CapsoVision Frequently Asked Questions (FAQ)
When was CapsoVision founded?
CapsoVision was founded in 2006.
Where is CapsoVision's headquarters?
CapsoVision's headquarters is located at 18805 Cox Avenue, Saratoga.
What is CapsoVision's latest funding round?
CapsoVision's latest funding round is IPO.
How much did CapsoVision raise?
CapsoVision raised a total of $99.29M.
Who are the investors of CapsoVision?
Investors of CapsoVision include Taiwan Global Angels and Paycheck Protection Program.
Who are CapsoVision's competitors?
Competitors of CapsoVision include True Digital Surgery, Digirad, SynergEyes, Visioneering Technologies, WaveTec Vision and 7 more.
Loading...
Compare CapsoVision to Competitors
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

Gamma Medica-Ideas provides digital marketing solutions in the marketing and advertising industry. The company offers services including marketing strategy development, digital marketing services, small business coaching, and strategic audits and roadmaps. They primarily cater to the pet industry and brands looking to enhance their marketing efforts. It is based in Northridge, California.

Holochip is a company that operates in defense and technology, specializing in artificial intelligence, simultaneous localization and mapping (SLAM), augmented reality (AR), and display solutions. The company provides products such as AR headsets and development kits for SLAM technology, as well as software development services for the AR/VR/XR ecosystem. Holochip serves sectors that require cybersecurity and spatial computing capabilities. It was founded in 2002 and is based in Albuquerque, New Mexico.

Dornier MedTech is a company that develops urological medical devices within the healthcare sector. The company produces products including shock wave lithotripsy systems, endoscopic instruments, and laser technologies to address urological conditions. Dornier MedTech serves healthcare providers in the urology field, focusing on conditions such as urolithiasis and benign prostatic hyperplasia. It is based in Kennesaw, Georgia.

Bodyviz provides 3D anatomy learning platforms within the education technology sector. The company offers software that allows interactive, virtual dissection and exploration of real human and animal anatomy, designed for students and instructors. Bodyviz serves the educational sector, including high schools, undergraduate and postgraduate institutions, and veterinary science programs. It is based in Ames, Iowa.

Symetrica specializes in operational security threat detection and identification within the homeland security and military sectors. The company offers a range of radiation detection systems, including handheld devices, mobile units, and software applications that integrate various detection technologies into a centralized interface for ease of use. Symetrica primarily serves customs organizations, government departments, and military contracts globally. It was founded in 2002 and is based in Southampton, England.
Loading...